Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 6/20 | 0.49 |
| ▸ | ITGAV | P06756 | 6/20 | 0.49 |
| ▸ | ITGB5 | P18084 | 4/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.49 |
| ▸ | ITGB6 | P18564 | 1/20 | 0.49 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.47 |
| ▸ | MC4R | P32245 | 10/20 | 0.46 |
| ▸ | MC5R | P33032 | 10/20 | 0.46 |
| ▸ | MC3R | P41968 | 10/20 | 0.46 |
| ▸ | MC1R | Q01726 | 10/20 | 0.46 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.45 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.45 |
| ▸ | KDM4A | O75164 | 1/20 | 0.44 |
| ▸ | TSLP | Q969D9 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12468724 | 0.94 | ITGB3 (0.47) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| SCHEMBL12467279 | 0.94 | ITGB3 (0.49) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| Cilengitide SCHEMBL22594705 | 0.93 | ITGB3 (0.59) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| Cilengitide SCHEMBL451423 | 0.93 | ITGB3 (0.59) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| Cilengitide SCHEMBL16920496 | 0.93 | ITGB3 (0.59) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| SCHEMBL16923811 | 0.91 | ITGB3 (0.52) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| SCHEMBL12016720 | 0.88 | ITGB3 (0.46) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| SCHEMBL24202406 | 0.86 | ITGB3 (0.48) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| SCHEMBL22807659 | 0.86 | ITGB3 (0.48) | ITGB3ITGAVITGB5ITGA2BITGB6 | |
| SCHEMBL16920494 | 0.86 | ITGB3 (0.51) | ITGB3ITGAVITGB5ITGA2BITGB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3243530-A1 | INTEGRIN RECEPTOR ANTAGONISTS AND THEIR USE | Allegro Pharmaceuticals, Inc. (US) | 2017-11-15 | — | — | EP | disclosed |